What Causes Pelvic Phleboliths & Should You Worry?

Uncover how pelvic phleboliths develop and what they signify for your well-being. Get clear, informed answers about these common findings.

Pelvic phleboliths are small, round calcified deposits that form inside the veins of the pelvis, and in the vast majority of cases they are completely harmless. Somewhere between 39% and 48% of adults have them, making phleboliths one of the most common incidental findings on abdominal X-rays and CT scans. They cause no symptoms on their own and rarely require any treatment, but they do create a persistent headache for radiologists and emergency physicians because they can look a lot like kidney stones on imaging.

What Phleboliths Actually Are

A phlebolith is, at its core, a tiny blood clot that calcified. Blood flow through pelvic veins can slow or pool, particularly in the small venous networks around the bladder, rectum, and reproductive organs. When a clot forms in one of these low-pressure veins and stays put long enough, the body gradually deposits layers of calcium and fibrous tissue around it. Under a microscope, phleboliths consist of calcified laminated fibrous tissue with an outer layer that blends right into the lining of the vein wall. Think of them like tiny pearls forming inside a vein instead of an oyster, with each successive layer of calcium wrapping around the original clot.

They were first described in the 19th century, when anatomists noticed small calcified nodules inside veins during dissection. Once X-ray imaging arrived in 1895, phleboliths became a regular and often confusing feature on pelvic radiographs. That confusion has persisted for well over a century.

How Common They Are

Phleboliths are remarkably prevalent. One study of 1,000 people aged 16 to 79 found them in about 44% of subjects overall. Women had them slightly more often than men, at roughly 50% versus 37%, and the difference was most pronounced between the ages of 35 and 54. The older the person, the greater the number of phleboliths found. Other reviews have placed the adult prevalence at 39% to 48%, which lines up well.

The gender gap is worth a brief pause. The pelvis in women contains a richer network of veins around the uterus and ovaries, which may create more opportunities for slow blood flow and tiny clot formation. Pregnancy, with its dramatic increase in pelvic blood volume and venous pressure, likely contributes too. After age 55 or so, the difference between men and women narrows, and phleboliths become roughly equal-opportunity.

Young people, by contrast, almost never have them. A study evaluating adolescents with suspected kidney stones noted that phleboliths are rarely seen in that age group. This makes intuitive sense: decades of slow venous pooling and minor clotting events are needed for calcium deposits to accumulate. When a young person does have visible pelvic phleboliths, it can actually be a diagnostic clue pointing to an underlying vascular condition rather than a normal finding.

Why Some People Get More Than Others

Age is the strongest predictor, but geography matters in a way that is hard to ignore. Phleboliths are more commonly seen in individuals from economically developed countries. The leading hypothesis ties this to diet, specifically to low fiber intake. The reasoning goes something like this: a low-fiber diet leads to smaller, harder stools and more straining during bowel movements, which increases pressure in the pelvic veins over time. That chronic venous pressure encourages both stagnant blood flow and small clot formation, which eventually calcify into phleboliths.

This same dietary pattern has long been invoked to explain why diverticular disease of the colon is so common in Western populations, and researchers have explored whether phleboliths and diverticula share a common cause. A study examining barium enema results in over 200 patients aged 60 to 69 found no statistical link between simply having phleboliths and having diverticular disease. However, when phleboliths were present, their number and size did correlate with the severity of diverticular disease. In other words, having a handful of phleboliths does not predict diverticula, but having a lot of large ones might signal that the same chronic pressure problem is affecting both the veins and the colon wall.

Sedentary lifestyle and prolonged sitting are often mentioned as risk factors in clinical discussions, though the evidence here is more circumstantial than rigorous. The logic is similar to the diet story: anything that promotes chronic venous stasis in the pelvis could theoretically encourage phlebolith formation. Obesity, chronic constipation, and conditions that raise intra-abdominal pressure all fit that pattern.

The Real Problem With Phleboliths

Phleboliths themselves are nearly always benign. The issue is what they look like on imaging. On a plain X-ray or a CT scan without contrast, a round pelvic phlebolith can be nearly indistinguishable from a distal ureteral stone, which is a kidney stone that has traveled down the ureter and is sitting near the bladder. This is not a minor academic concern. Multiple studies show that phleboliths appear on CT imaging at frequencies equal to or greater than ureteral stones. So when someone arrives at the emergency department with flank pain and a scan reveals a small calcification in the pelvis, the stakes of telling the two apart are real: one is an incidental finding that can be ignored, the other may need urgent treatment.

Getting this wrong in either direction has consequences. If a phlebolith is mistaken for a kidney stone, you might undergo unnecessary procedures, extra scans, or a prolonged hospital stay. If an actual stone is dismissed as a phlebolith, the stone could obstruct the ureter, cause kidney damage, or lead to infection. The diagnostic overlap between these two entities has been a source of frustration for urologists and radiologists since the earliest days of X-ray imaging.

How Doctors Tell Phleboliths From Kidney Stones

Radiologists rely on several visual clues to distinguish phleboliths from ureteral stones on CT scans, though none is perfectly reliable on its own.

  • Central lucency: Phleboliths often have a dark center, like a tiny donut, because the original clot in the middle is less dense than the calcified shell. Kidney stones tend to be uniformly dense. This is the classic teaching-point distinction, though it does not always show up clearly on every scan.
  • Comet-tail sign: A phlebolith may appear to have a small “tail” of soft tissue trailing from it, representing the vein it sits within. The presence of this tail is highly specific for phleboliths. One study found the tail sign had a specificity of 100% for phleboliths, meaning that when the tail was visible, it was never a kidney stone. But the tail only showed up about 65% of the time, so its absence did not rule out a phlebolith.
  • Tissue rim sign: A ureteral stone typically shows a thin ring of swollen tissue around it on CT, the inflamed wall of the ureter being squeezed by the stone. Phleboliths do not produce this rim. But radiologists can disagree on whether the rim is present, and one study designed to assess how consistently different radiologists identified the rim and comet-tail signs found significant variability between readers.
  • Location: Phleboliths tend to sit within veins that run lateral to the expected path of the ureter. Stones, by definition, are inside the ureter. On a good-quality CT scan, a radiologist can often trace the ureter and determine whether the calcification is inside or outside it. But when the ureter is not dilated or easily visible, this gets harder.

No single sign is foolproof. In practice, radiologists combine several features and weigh them against the clinical picture: does the patient have symptoms consistent with a kidney stone? Is there hydronephrosis (swelling of the kidney from backup of urine)? These contextual factors often matter as much as the imaging features themselves.

Artificial Intelligence Is Getting Better at This

The difficulty of distinguishing phleboliths from stones has attracted interest from machine-learning researchers. A study using a convolutional neural network trained on CT images found that the algorithm could differentiate ureteral stones from phleboliths with about 92% accuracy, compared to an average radiologist accuracy of 86%. The difference was statistically significant. A simpler, semi-quantitative scoring method that tried to combine traditional imaging signs managed only 49% accuracy, which is essentially a coin flip. These tools are not yet in widespread clinical use, but they point toward a future where the phlebolith-versus-stone question is settled more reliably and faster, particularly in busy emergency departments.

Rare Situations Where Phleboliths Do Matter

For the overwhelming majority of people, phleboliths are incidental findings that need no treatment or follow-up. But there are uncommon exceptions worth knowing about.

In very rare cases, phleboliths have been associated with pelvic vein thrombosis. A case report described two patients whose phleboliths were linked to thrombotic events in the pelvic veins. Whether the phleboliths caused the thrombosis or simply reflected the same underlying tendency toward abnormal clotting is not entirely clear. This is genuinely rare, and the presence of phleboliths on your scan is not a reason to worry about blood clots. But if someone has a known clotting disorder and develops pelvic symptoms, the phleboliths may be part of the clinical picture rather than entirely separate from it.

Phleboliths also take on a different meaning in certain vascular malformation syndromes. The most well-known is Klippel-Trenaunay syndrome, a condition involving abnormal blood vessel development, limb overgrowth, and port-wine birthmarks. In children and infants with this syndrome, visible calcified phleboliths on plain X-rays can serve as a diagnostic clue pointing toward the underlying vascular malformation. In this context, the phleboliths are not the problem themselves but rather a visible marker of abnormal venous anatomy. Children with unexplained pelvic phleboliths, especially alongside symptoms like blood in the urine or rectal bleeding, warrant further evaluation.

What to Do if Your Scan Shows Phleboliths

If a radiologist’s report mentions pelvic phleboliths, and you were being scanned for something unrelated, the appropriate response is almost always nothing. They do not need treatment, monitoring, or removal. No dietary change, supplement, or exercise will dissolve them, because they are essentially tiny calcified fossils inside veins that continue to function normally around them.

If you went to the emergency room with pain suspicious for a kidney stone and the scan found a pelvic calcification, the more relevant question is whether it is actually a stone or a phlebolith. Your doctor will look at the imaging features discussed above, correlate them with your symptoms, and may check for signs of urinary obstruction. If everything points to a phlebolith and there is no evidence of a blocked ureter, you can take some comfort in the fact that what showed up on the scan is overwhelmingly likely to be a harmless piece of calcified vein wall that has probably been there for years.

The one scenario where phleboliths deserve more attention is when they appear in someone young, particularly a child. Since phleboliths are rarely seen in adolescence, their presence in a younger person is unusual enough to prompt a closer look at the underlying vascular anatomy. This does not mean something is necessarily wrong, but it falls outside the normal pattern and may warrant a conversation with a specialist.

Phleboliths and Chronic Pelvic Pain

People sometimes wonder whether their pelvic phleboliths could be the source of chronic pelvic pain, especially when other explanations have been exhausted. The honest answer is that phleboliths are not established as a cause of pelvic pain in the medical literature. However, they often coexist with conditions that are known to cause pain, such as pelvic congestion syndrome, a condition in which the veins of the pelvis become dilated and engorged. Pelvic congestion syndrome involves the same sluggish venous blood flow that promotes phlebolith formation, so finding phleboliths in someone with pelvic congestion is expected but does not mean the phleboliths are generating the discomfort. The enlarged veins themselves, and the inflammatory environment around them, are the more likely pain generators. If you have chronic pelvic pain and your imaging shows phleboliths, the phleboliths are probably bystanders rather than culprits, and your doctor will look for other explanations.

Why Phleboliths Are More Common in Developed Countries

The geographic pattern is one of the more curious aspects of phlebolith epidemiology. Phleboliths are strikingly more prevalent in Western, industrialized populations compared to populations in developing regions. The most widely cited explanation centers on dietary fiber. Low-fiber diets lead to chronic constipation and straining, which raises venous pressure in the pelvis over years and decades. This same mechanism has been proposed for the higher rates of hemorrhoids and varicose veins in developed nations.

Sedentary occupations may compound the effect. Prolonged sitting reduces the return of blood from the pelvis, allowing it to pool in the venous plexuses. Combine that with a diet low in fiber and high in processed food, and you get a population-wide recipe for sluggish pelvic circulation. There is no definitive interventional study proving that eating more fiber or sitting less prevents phleboliths, and it would be difficult to design one since phleboliths accumulate over decades and cause no symptoms to track. But the epidemiological pattern is consistent enough that researchers have been comfortable attributing a good portion of the geographic variation to lifestyle factors.

Some researchers have also pointed to obesity and reduced physical activity as contributing factors, both of which raise intra-abdominal pressure and reduce the efficiency of venous return from the lower body. The truth is likely a combination of all these factors layered on top of the simple reality that modern populations live longer, and more years means more time for tiny venous clots to calcify and accumulate in the pelvic veins.